colitis and glp-1 GLP-1R Agonists Their Therapeutic Potential in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases, a Systematic Review of the Literature Frontiers | GLP-1 and GLP-2

In 2021, diabetes was responsible for 6.7 million deaths, and it is projected that by 2045, the number of individuals with diabetes will increase to 783 million, highlighting the growing global burden of T2DM over the coming decades (Sun et al., 2022)

The study compared patients who were prescribed GLP-1 medications with those who were not

The GHK tripeptide acts as a carrier that delivers copper to cellular targets, where it participates in enzymatic reactions critical to collagen cross-linking, antioxidant defence, and gene expression modulation

When to reduce the dose Dose reduction is not failure

What works during your first month might need adjustment as your body adapts to the medication and as your weight changes